Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays. OH&RM [Internett]. 13. desember 2023 [sitert 22. juli 2026];:77. Tilgjengelig på: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657